Caplight Directory>Companies>Engram-preview>Neurofundus


Engram

Engram

Private
—Healthcare & Life Scienceshttps://www.neurofundus.com/

Last Round

Accelerator

Feb 9, 2026

Company Overview

Engram is a healthcare technology company developing foundation models for precision psychiatry.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Drug Discovery, Precision Medicine, Mental Health

Business Model

B2B

Customer Profile

Data as a Service, Subscription SaaS, Services & Consulting

AI Layer

Foundation

Keywords

precision psychiatryfoundation modelsprecision drug discoveryAI for mental healthAI drug discoveryfrontier AI labdrug discovery platformmental health techcomputational psychiatrypersonalized treatmentmultimodal data analysisdisease subtype mappinggenerative biologyOrganoids as a service

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Engram Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Engram Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
AcceleratorFeb 9, 2026
View all Funding Rounds

Engram Investors

Notable investors and investment history

InvestorRounds
One MindAccelerator
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 9, 2026

    Funded by One Mind, a venture capital (not-for-profit).

View all signals

Engram Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Engram Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Engram's valuation, stock price, and market status.

Firmographic Details

Headquarters—
Year FoundedN/A
Last FundingFeb 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.